Programs & Projects

Active Pharmaceutical Ingredients (APIs) play an important role in the quality and cost of medicines, but so far very little is known about the market structure, cost drivers, and incentives for capacity expansion for key APIs in HIV/AIDS, malaria, and TB drugs. WDI is helping to generate new information and thinking around the competitive landscape, market needs and opportunities in the upstream production stages of manufacturing across these three therapeutic areas. Better visibility into the API and finished product markets will help inform future global health work and continued improvements in access to HIV/AIDS, malaria, and TB medicines.